Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K R Harrap

Showing results (51-60 of 138) with videos related to

Pageof 14
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1991
Antimetabolites in cancer chemotherapyS J Clarke, A L Jackman, K R Harrap
European Journal of Cancer|August 1, 1972
Methotrexate toxicity: correlation with duration of administration, plasma levels, dose and excretion patternJ H Goldie, L A Price, K R Harrap
Chemico-Biological Interactions|July 1, 1977
Enhancement of the therapeutic effectiveness of methotrexate and protection of normal proliferating tissues with purines and pyrimidinesK R Harrap, G A Taylor, G P Browman
British Journal of Cancer|January 1, 1993
Acquisition of platinum drug resistance and platinum cross resistance patterns in a panel of human ovarian carcinoma xenograftsM Jones, J Siracky, L R Kelland, et al.
Acta Pharmacologica Et Toxicologica|February 1, 1981
Studies on the mechanism of action of LS 1727, a nitrosocarbamate of 19-nortestosteroneB Hartley-Asp, R Wilkinson, S Venitt, et al.
Cancer Research|February 1, 1994
Lack of neurotoxicity of oral bisacetatoamminedichlorocyclohexylamine-platinum(IV) in comparison to cisplatin and tetraplatin in the ratM J McKeage, F E Boxall, M Jones, et al.
Advances in Experimental Medicine and Biology|January 1, 1984
Purine deoxyribonucleoside induced hepatotoxicity in the mouseJ Renshaw, R M Paine, G A Taylor, et al.
International Journal of Cancer|November 11, 1993
Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell linesP Mistry, S Y Loh, L R Kelland, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Comparative distribution and excretion of carboplatin and cisplatin in miceZ H Siddik, M Jones, F E Boxall, et al.
British Journal of Cancer|January 1, 1994
Mechanism of action of an orally administered platinum complex [ammine bis butyrato cyclohexylamine dichloroplatinum (IV) (JM221)] in intrinsically cisplatin-resistant human ovarian carcinoma in vitroM J McKeage, G Abel, L R Kelland, et al.
Pageof 14

Showing results (51-60 of 138) with videos related to

Sort By:
Pageof 14
Advances in Experimental Medicine and Biology|January 1, 1991
Antimetabolites in cancer chemotherapyS J Clarke, A L Jackman, K R Harrap
European Journal of Cancer|August 1, 1972
Methotrexate toxicity: correlation with duration of administration, plasma levels, dose and excretion patternJ H Goldie, L A Price, K R Harrap
Chemico-Biological Interactions|July 1, 1977
Enhancement of the therapeutic effectiveness of methotrexate and protection of normal proliferating tissues with purines and pyrimidinesK R Harrap, G A Taylor, G P Browman
British Journal of Cancer|January 1, 1993
Acquisition of platinum drug resistance and platinum cross resistance patterns in a panel of human ovarian carcinoma xenograftsM Jones, J Siracky, L R Kelland, et al.
Acta Pharmacologica Et Toxicologica|February 1, 1981
Studies on the mechanism of action of LS 1727, a nitrosocarbamate of 19-nortestosteroneB Hartley-Asp, R Wilkinson, S Venitt, et al.
Cancer Research|February 1, 1994
Lack of neurotoxicity of oral bisacetatoamminedichlorocyclohexylamine-platinum(IV) in comparison to cisplatin and tetraplatin in the ratM J McKeage, F E Boxall, M Jones, et al.
Advances in Experimental Medicine and Biology|January 1, 1984
Purine deoxyribonucleoside induced hepatotoxicity in the mouseJ Renshaw, R M Paine, G A Taylor, et al.
International Journal of Cancer|November 11, 1993
Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell linesP Mistry, S Y Loh, L R Kelland, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Comparative distribution and excretion of carboplatin and cisplatin in miceZ H Siddik, M Jones, F E Boxall, et al.
British Journal of Cancer|January 1, 1994
Mechanism of action of an orally administered platinum complex [ammine bis butyrato cyclohexylamine dichloroplatinum (IV) (JM221)] in intrinsically cisplatin-resistant human ovarian carcinoma in vitroM J McKeage, G Abel, L R Kelland, et al.
Pageof 14